Ouabainlike compound in hypertension associated with ectopic corticotropin syndrome

Hypertension

Volumn 28, Issue 3, 1996, Pages 421-425

  Goto, Atsuo ^a   Yamada, Kaoru ^b   Hazama, Hisanori ^a   Uehara, Yoshio ^a   Atarashi, Keiichiro ^a   Hirata, Yasunobu ^a   Kimura, Kenjiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Sanraku Hospital   (Japan)

Author keywords

adrenocorticotropic hormone; blood pressure; hormones; Na+,K+ transporting ATPase; potassium; sodium; sodium potassium pump

Indexed keywords

17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CORTICOTROPIN; DIGITALIS LIKE FACTOR; HYDROCORTISONE; MINERALOCORTICOID; RENIN; SODIUM ION; VASOPRESSIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CUSHING SYNDROME; ECTOPIC CORTICOTROPIN PRODUCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOKALEMIA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM RETENTION;

EID: 0029795467     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.421     Document Type: Article

References (40)

1. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP. Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
2. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J-M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-suppressible aldosteronism and human hypertension. Nature. 1992;355:262-265.
3. Mune T, Rogerson FM, Nikkilä H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399.
4. Beretta-Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AMM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Robertson JIS, Weidman P, Williams ED. Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci. 1982;63:257-270.
5. Beretta-Piccoli C, Davies DL, Brown JJ, Ferris JB, Fraser R, Lever AF, Morton JJ, Robertson JIS. The relation of arterial pressure with plasma and body electrolytes is similar in Conn's syndrome and essential hypertension. Clin Sci. 1982;63:89s-92s.
6. Haddy FJ, Overbeck HW. The role of humoral agents in volume expanded hypertension. Life Sci. 1976;19:935-948.
7. De Wardener HE, MacGregor GA. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int. 1980;18:1-9.
8. 2+ stores and cell responsiveness. Am J Physiol. 1993;264:C1367-C1387.
9. Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev. 1992;44:377-399.
10. Hollenberg NK, Graves SW. Koch's postulates and the digitalis-like factor. Hypertens Res. 1995;18:1-6.
11. Hamlyn JM, Blaustein MP, Bova S, Ducharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A. 1991;88:6259-6263.
12. Tymiak AA, Norman JA, Bolger M, DiDonato GC, Lee H, Parker WL, Lo L-C, Berova N, Nakanishi K, Haber E, Haupert GT. Physicochemical characterization of an ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci U S A. 1993;90:8189-8193.
13. Zhao N, Lo L-C, Berova N, Nakanishi K, Tymiac AA, Ludens JH, Haupert GT. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry. 1995;34:9893-9896.
14. Lichtstein D, Gati I, Samuelov S, Berson D, Rozenman Y, Landau L, Deutsch J. Identification of digitalis-like compounds in human cataractous lenses. Eur J Biochem. 1993;216:261-268.
15. +-ATPase-specific inhibitor from pig urine. Eur J Biochem. 1993;211:317-327.
16. Graves SW, Glatter KA, Lazarus JM, Williams GH, Hollenberg NK. Volume expansion in renal failure patients: a paradigm for a clinically relevant [Na,K]ATPase inhibitor. J Cardiovasc Pharmacol. 1993; 22(suppl 2):S54-S57.
17. Yamada K, Goto A, Hui C, Yagi N, Nagoshi H, Sasabe M, Sugimoto T. Role of ouabainlike compound in rats with reduced renal masssaline hypertension. Am J Physiol. 1994;266:H1357-H1362.
18. Yuan C, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ, Pamnani M. Long-term ouabain administration produces hypertension in rats. Hypertension. 1993;22:178-187.
19. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994;12:569-576.
20. Gomez-Sanchez EP, Gomez-Sanchez CE, Fort C. Immunization of Dahl SS/jr with an ouabain conjugate mitigates hypertension. Am J Hypertens. 1994;7:591-596.
21. Huang BS, Huang X, Harmsen E, Leenen FHH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension. 1994;23:1087-1090.
22. Goto A, Yamada K, Yagi N, Nagoshi H, Hui C, Sugimoto T. Novel concepts on the roles of ouabainlike compound in hypertension. J Hypertens. 1992;10:S50. Abstract.
23. Goto A, Yamada K, Ishii M, Sugimoto T. Release of endogenous digitalis-like factor with sodium loading. N Engl J Med. 1989; 320:124-125.
24. Odell WD. Ectopic ACTH secretion, a misnomer. Endocrinol Metab Clin N Am. 1991;20:371-379.
25. Ulick S, Jennifer ZW, Blumenfeld JD, Pickering TG. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotrophin syndrome. J Clin Endocrinol Metab. 1992;74:963-967.
26. Masugi F, Ogihara T, Hasegawa T, Tomii A, Nagano M, Higashimori K, Kumahara K, Terano Y. Circulating factor with ouabain-like immunoreactivity in patients with primary aldosteronism. Biochem Biophys Res Commun. 1986;135:41-45.
27. Naruse K, Naruse M, Tanabe A, Yoshimoto T, Tanaka M, Watanabe Y, Kurimoto F, Horiba N, Tamura M, Inagami T, Demura H. Does plasma immunoreactive ouabain originate from the adrenal gland? Hypertension. 1994;23(suppl I):I-102-I-105.
28. Rossi G, Manunta P, Hamlyn JM, Pavan E, De Toni R, Semplicini A, Pessina AC. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationships with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995; 13:1181-1192.
29. Bova S, Blaustein MP, Ludens JH, Harris DW, Ducharme DW, Hamlyn JM. Effects of an endogenous ouabainlike compound on heart and aorta. Hypertension. 1991;17:944-950.
30. Doris PA, Jenkins LA, Stocco DM. Is ouabain an authentic endogenous mammalian substance derived from the adrenal? Hypertension. 1994;23:632-638.
31. Laredo J, Hamilton BP, Hamlyn JM. Ouabain is secreted by bovine adrenocortical cells. Endocrinology. 1994;135:794-797.
32. Manunta P, Evans G, Hamilton BP, Gann D, Resau J, Hamlyn JM. A new syndrome with elevated plasma ouabain and hypertension secondary to an adrenocortical tumor. J Hypertens. 1992;10(suppl 6):27. Abstract.
33. Pamnani MB, Whitehorn WV, Clough DL, Haddy FJ. Effects of canrenone on blood pressure in rats with reduced renal mass. Am J Hypertens. 1990;3:188-195.
34. Woolf AD, Wenger T, Smith TW, Levojoy FH. The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. N Engl J Med. 1992;326:1739-1744.
35. Szylman P, Wolach B, Winaver J, Panett R, Cohen P, Schenkman L, Better OS. Nonazotemic hyperkalemia with renal and extrarenal defects in potassium transport: association with high levels of digoxin-like immunoreactive factor. J Lab Clin Med. 1990;116:315-326.
36. Bagrov AY, Kuznetsova EA, Fedorova OV. Endogenous digoxin-like factor in acute myocardial infarction. J Intern Med. 1994;235:63-67.
37. Bulpit CJ, Shipley MJ, Semmence A. Blood pressure and plasma sodium and potassium. Clin Sci. 1981;61:85S-87S.
38. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med. 1989;320:1177-1182.
39. Krishna GG, Kapoor S. Potassium depletion exacerbates essential hypertension. Ann Intern Med. 1991;115:77-83.
40. +-ATPase. Fed Proc. 1983;42:239-245.